世界经济论坛-变革处方：妇女健康研究的政策建议（英）

Prescription for Change: Policy Recommendations for Women’s Health ResearchW H I T E P A P E RM A Y 2 0 2 5In collaboration with the Global Alliance for Women’s Health, Kearney and the Gates FoundationImages: Midjourney, Getty ImagesDisclaimer This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings, interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic Forum but whose results do not necessarily represent the views of the World Economic Forum, nor the entirety of its Members, Partners or other stakeholders.© 2025 World Economic Forum. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, including photocopying and recording, or by any information storage and retrieval system.ContentsForewordExecutive summaryIntroduction: The case for women’s health policy transformation1 Unlock innovation in women’s health1.1 Women’s health is underfunded and under-researched1.2 Success in orphan and paediatric diseases: Incentives drive investment and innovation1.3 Policy recommendations to unlock innovation in women’s health2 Expand the inclusion of women in clinical trials2.1 Women remain under-represented in clinical trials2.2 Success in paediatrics: Requirements and incentives drive inclusion2.3 Recent guidelines and initiatives start to focus on inclusion2.4 Policy recommendations to expand the inclusion of women in clinical trials3 Enhance disaggregation of clinical trial data3.1 Policy recommendations to enhance disaggregation of clinical trial data4 Design clinical trials with women in mind4.1 Policy recommendations to design clinical trials with women in mind5 Deepen insights into sex-specific differences5.1 Policy recommendations to deepen insights into sex-specific differencesConclusionContributorsAcknowledgementsEndnotes346991010121213131416161818202022232325Prescription for Change: Policy Recommendations for Women’s Health Research2ForewordThe World Economic Forum’s Global Alliance for Women’s Health, in partnership with Kearney and the Gates Foundation, is pleased to present this white paper proposing key policy recommendations to protect improvements already made in women’s health science and innovation and to promote further progress.Addressing the women’s health research gap is not only an ethical imperative but also a critical step towards transforming global health outcomes. Women’s health has historically been under-researched and underfunded, leading to gaps in knowledge and innovation. Despite comprising half the world’s population, women have also been under-represented in clinical research, resulting in significant disparities in the understanding of men’s and women’s physiology. These disparities have far-reaching implications, influencing diagnosis, treatm